Artventive Medical Group Inc (AVTD) financial statements (2020 and earlier)

Company profile

Business Address 2766 GATEWAY ROAD
CARLSBAD, CA 92009
State of Incorp. NV
Fiscal Year End December 31
SIC 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

9/30/2016
TTM
12/31/2015
12/31/2014
12/31/2013
12/31/2012
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments 221041,6271,036
Cash and cash equivalents 221041,6271,036
Inventory, net of allowances, customer advances and progress billings 303 
Inventory 303   
Prepaid expense 1219
Other undisclosed current assets 184627(512)
Total current assets: 3551511,663524
Noncurrent Assets
Property, plant and equipment 1712144
Other undisclosed noncurrent assets 82255151
Total noncurrent assets: 99376555
TOTAL ASSETS: 4531891,728579
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities 9241,265858 
Accounts payable 924221273 
Accrued liabilities  1,043586 
Other undisclosed current liabilities    160
Total current liabilities: 9241,265858160
Noncurrent Liabilities
Long-term debt and lease obligation 500500  
Long-term debt, excluding current maturities 500500  
Total noncurrent liabilities: 500500  
Total liabilities: 1,4241,765858160
Stockholders' equity
Stockholders' equity attributable to parent, including: (971)(1,576)869419
Additional paid in capital 17,02912,8809,0565,114
Other undisclosed stockholders' equity attributable to parent (17,999)(14,456)(8,187)(4,695)
Total stockholders' equity: (971)(1,576)869419
TOTAL LIABILITIES AND EQUITY: 4531891,728579

Income statement (P&L) ($ in thousands)

9/30/2016
TTM
12/31/2015
12/31/2014
12/31/2013
12/31/2012
Revenues 230112  
Cost of revenue
(Cost of Goods and Services Sold)
 (230)(112)  
Operating expenses (3,548)(6,274)(3,497)(858)
Other undisclosed operating loss    (0)
Operating loss: (3,548)(6,274)(3,497)(858)
Nonoperating income
(Investment Income, Nonoperating)
    0
Net loss: (3,548)(6,274)(3,497)(858)
Other undisclosed net income attributable to parent 011 
Net loss available to common stockholders, diluted: (3,548)(6,273)(3,496)(858)

Comprehensive Income ($ in thousands)

9/30/2016
TTM
12/31/2015
12/31/2014
12/31/2013
12/31/2012
Net loss: (3,548)(6,274)(3,497)(858)
Comprehensive loss: (3,548)(6,274)(3,497)(858)
Other undisclosed comprehensive income, net of tax, attributable to parent 011 
Comprehensive loss, net of tax, attributable to parent: (3,548)(6,273)(3,496)(858)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: